JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
XOG
4676
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $118K | ﹤0.01% |
27,492
+20,480
| +292% | +$87.7K |
2019 Q1
1 quarter
|
|
|
ASNA
4677
DELISTED
Ascena Retail Group, Inc.
ASNA
| $118K | ﹤0.01% |
10,509
+8,373
| +392% | +$178K |
2017 Q3
7 quarters
|
|
4678
Brown-Forman Class A
BF.A
$12.3B
| $117K | ﹤0.01% |
2,123
-616
| -22% | -$32.3K |
2015 Q4
14 quarters
|
|
4679
Collegium Pharmaceutical
COLL
$712M
| $117K | ﹤0.01% |
8,828
+482
| +6% | +$6.45K |
2017 Q3
7 quarters
|
|
4680
Invesco S&P 500 Quality ETF
SPHQ
$19B
| $116K | ﹤0.01% |
3,510
-2,162
| -38% | -$70.6K |
2018 Q2
4 quarters
|
|
4681
White Mountains Insurance
WTM
$4.82B
| $116K | ﹤0.01% |
114
-10,850
| -99% | -$10.4M |
2017 Q4
6 quarters
|
|
|
CAI
4682
DELISTED
CAI International, Inc.
CAI
| $115K | ﹤0.01% |
4,645
+445
| +11% | +$10.6K |
2017 Q3
7 quarters
|
|
4683
Lexicon Pharmaceuticals
LXRX
$774M
| $114K | ﹤0.01% |
18,550
+2,808
| +18% | +$16.8K |
2015 Q3
15 quarters
|
|
4684
Neurogene
NGNE
$530M
| $114K | ﹤0.01% |
2,390
-4,521
| -65% | -$232K |
2018 Q3
3 quarters
|
|
4685
PUT
Under Armour
UAA
$2.02B
| $114K | ﹤0.01% |
4,500
| – | – |
2019 Q1
1 quarter
|
|
|
FRGI
4686
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $114K | ﹤0.01% |
8,860
-90,082
| -91% | -$1.2M |
2016 Q4
10 quarters
|
|
4687
BRC Group Holdings
RILY
$196M
| $113K | ﹤0.01% |
5,544
+493
| +10% | +$9.41K |
2017 Q4
6 quarters
|
|
4688
Global X SuperDividend REIT ETF
SRET
$204M
| $113K | ﹤0.01% |
2,567
| – | – |
2018 Q4
2 quarters
|
|
4689
CALL
Willis Towers Watson
WTW
$26.8B
| $113K | ﹤0.01% |
+600
| New | +$109K |
2019 Q2
0 quarters
|
|
|
4690
PUT
Willis Towers Watson
WTW
$26.8B
| $113K | ﹤0.01% |
+600
| New | +$109K |
2019 Q2
0 quarters
|
|
|
HOME
4691
DELISTED
At Home Group Inc.
HOME
| $113K | ﹤0.01% |
16,732
+3,213
| +24% | +$56.9K |
2017 Q4
6 quarters
|
|
|
LN
4692
DELISTED
LINE Corporation
LN
| $113K | ﹤0.01% |
3,965
+1,348
| +52% | +$42.4K |
2017 Q2
8 quarters
|
|
|
EMCI
4693
DELISTED
EMC INS Group Inc
EMCI
| $113K | ﹤0.01% |
3,142
+745
| +31% | +$25.6K |
2016 Q4
10 quarters
|
|
4694
Sprott Physical Gold and Silver Trust
CEF
$7.28B
| $112K | ﹤0.01% |
8,333
-5,452
| -40% | -$68.1K |
2018 Q1
5 quarters
|
|
|
AINC
4695
DELISTED
Ashford Inc.
AINC
| $112K | ﹤0.01% |
3,617
+255
| +8% | +$12.2K |
2018 Q2
4 quarters
|
|
|
PYX
4696
DELISTED
Pyxus International, Inc.
PYX
| $112K | ﹤0.01% |
7,127
+1,681
| +31% | +$31.7K |
2018 Q3
3 quarters
|
|
4697
Equity Bancshares
EQBK
$979M
| $111K | ﹤0.01% |
4,151
+889
| +27% | +$23.7K |
2017 Q3
7 quarters
|
|
|
AKCA
4698
DELISTED
Akcea Therapeutics Inc
AKCA
| $111K | ﹤0.01% |
4,811
+186
| +4% | +$4.59K |
2017 Q3
7 quarters
|
|
|
IOTS
4699
DELISTED
Adesto Technologies Corp
IOTS
| $111K | ﹤0.01% |
21,042
+13,879
| +194% | +$99.5K |
2018 Q1
5 quarters
|
|
4700
MediciNova
MNOV
$86.1M
| $110K | ﹤0.01% |
11,383
-3,718
| -25% | -$39.2K |
2016 Q1
13 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.